Could Melatonin and Caffeine Work Together for Performance?

Why It Matters

The findings suggest athletes could pair nocturnal melatonin with morning caffeine to enhance high‑intensity output without compromising recovery, offering a nuanced ergogenic strategy. If confirmed, this approach could reshape supplementation protocols in competitive sports.

Key Takeaways

• Caffeine (3 mg/kg) boosted shuttle run distance versus placebo.
• Melatonin alone did not improve sleep quality in study.
• Combined melatonin (6 mg) and caffeine enhanced performance and reduced inflammation.
• Heart rate peaks were lower with melatonin‑caffeine combo.
• Small sample size limits generalizability; larger trials needed.

Pulse Analysis

Caffeine remains the most widely studied ergogenic aid, known for its ability to block adenosine receptors and reduce perceived fatigue. In elite training environments, athletes often seek complementary strategies to mitigate caffeine’s potential sleep disruption. Melatonin, a chronobiotic hormone, is popular for its sleep‑promoting properties and emerging antioxidant benefits. By administering 6 mg of melatonin before bedtime and 3 mg·kg⁻¹ of caffeine the next morning, the Tunisian‑Spanish‑Norwegian team created a controlled setting to test whether the two agents could synergize rather than counteract each other.

The study’s results were striking: while caffeine alone increased total shuttle‑run distance, the melatonin‑caffeine pairing produced comparable performance gains and, importantly, reduced peak heart‑rate responses and markers of muscle damage and inflammation. Sleep metrics remained unchanged across all conditions, indicating that a single 6 mg dose of melatonin did not significantly alter sleep architecture in this short‑term protocol. These physiological shifts suggest melatonin may modulate autonomic balance, tempering the cardiovascular strain typically associated with high‑intensity bouts, thereby preserving performance capacity for subsequent sessions.

For practitioners, the implication is a potential new supplementation window: a modest melatonin dose at night followed by a standard caffeine load before competition. However, the trial’s limited cohort of 14 male athletes restricts extrapolation to broader populations, including women and older competitors. Future research should explore dose‑response curves, timing variations, and long‑term effects on sleep quality and recovery. Until then, coaches should apply the combination cautiously, monitoring individual sleep patterns and cardiovascular responses.